Home » Avioq’s HIV Assay for Reactive Samples Gains CE Mark
Avioq’s HIV Assay for Reactive Samples Gains CE Mark
Avioq’s VioOne HIV Profile Supplemental Assay has earned the CE Mark and is seeking distribution partners for Europe.
The enzyme-linked immunosorbent assay (ELISA) confirms and distinguishes between individual antibodies directed to various gene products of HIV-1 and HIV-2 in human serum and blood plasma.
The test is specifically used to confirm the presence of HIV-1 or HIV-2 antibodies in specimens that were repeatedly reactive during diagnostic screening procedures.
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May